Real-time enrollment status for this focal segmental glomerulosclerosis clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT04065438 |
| Recruiting Status | Recruiting |
| Condition | Focal Segmental Glomerulosclerosis |
| Phase | NA |
| Target Enrollment | 35 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Kaneka Medical America LLC |
| Last Updated on CT.gov | August 28, 2026 (Aug 28, 2026) |
As of October 12, 2026: Clinical trial NCT04065438 is currently recruiting participants. This na study for focal segmental glomerulosclerosis is actively seeking new participants at 10 locations across the United States. The study is sponsored by Kaneka Medical America LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04065438 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04065438 was last updated Aug 28, 2026 (August 28, 2026). HelloStudys verifies this status automatically.